Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas A Di Prospero

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Muscle & Nerve|August 12, 2009
Standard and modified statistical MUNE evaluations in spinal-bulbar muscular atrophyTanya J Lehky, Cheun Ju Chen, Nicholas A di Prospero, et al.
Archives of Neurology|June 15, 2007
Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxiaNicholas A Di Prospero, Charlotte J Sumner, Scott R Penzak, et al.
Plos One|March 9, 2023
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpointsElias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, et al.
Archives of Physical Medicine and Rehabilitation|July 6, 2010
Exercise capacity and idebenone intervention in children and adolescents with Friedreich ataxiaBart E Drinkard, Randall E Keyser, Scott M Paul, et al.
Journal of Hepatology|October 10, 2022
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and consJuan M Pericàs, Frank Tacke, Quentin M Anstee, et al.
Plos Genetics|December 21, 2010
Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndromePeter K Todd, Seok Yoon Oh, Amy Krans, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) InhibitionDebapriya Basu, Lesley-Ann Huggins, Diego Scerbo, et al.
Epilepsy Research|February 25, 2014
Evaluation of JNJ-26489112 in patients with photosensitive epilepsy: a placebo-controlled, exploratory studyNicholas A Di Prospero, Jay J Gambale, Gahan Pandina, et al.
Molecular and Cellular Biology|July 30, 2004
Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient micePing Yu, Nicholas A Di Prospero, Michael T Sapko, et al.
Brain : a Journal of Neurology|February 1, 2013
Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient databaseGünther Metz, Nicholas Coppard, Jonathon M Cooper, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Muscle & Nerve|August 12, 2009
Standard and modified statistical MUNE evaluations in spinal-bulbar muscular atrophyTanya J Lehky, Cheun Ju Chen, Nicholas A di Prospero, et al.
Archives of Neurology|June 15, 2007
Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxiaNicholas A Di Prospero, Charlotte J Sumner, Scott R Penzak, et al.
Plos One|March 9, 2023
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpointsElias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, et al.
Archives of Physical Medicine and Rehabilitation|July 6, 2010
Exercise capacity and idebenone intervention in children and adolescents with Friedreich ataxiaBart E Drinkard, Randall E Keyser, Scott M Paul, et al.
Journal of Hepatology|October 10, 2022
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and consJuan M Pericàs, Frank Tacke, Quentin M Anstee, et al.
Plos Genetics|December 21, 2010
Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndromePeter K Todd, Seok Yoon Oh, Amy Krans, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) InhibitionDebapriya Basu, Lesley-Ann Huggins, Diego Scerbo, et al.
Epilepsy Research|February 25, 2014
Evaluation of JNJ-26489112 in patients with photosensitive epilepsy: a placebo-controlled, exploratory studyNicholas A Di Prospero, Jay J Gambale, Gahan Pandina, et al.
Molecular and Cellular Biology|July 30, 2004
Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient micePing Yu, Nicholas A Di Prospero, Michael T Sapko, et al.
Brain : a Journal of Neurology|February 1, 2013
Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient databaseGünther Metz, Nicholas Coppard, Jonathon M Cooper, et al.
Pageof 3